Just exploring this VLA / Merck scenario a bit further. After the sale of VLA Hopper used some of the money to work on the next generation of OV, CF33, with YF and a few others with his Vaxinia company in LA. And not too far the possibility that IMU and its current IP gets sold and the IMU team continues with even more money on the next generation of B-cell / OV within, for example, CHM or ALA or RAD - all ASX listed companies under his control.
Just speculation. Sell the old staff to big pharma for big money and re-start the cycle at a higher IP level.
GLTA
IMU Price at posting:
36.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)